Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study) ...Middle East

PR Newswire - Economy
Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study)
CLEVELAND, April 23, 2024 /PRNewswire/ -- Neuronoff, Inc., a pioneering medical device company dedicated to developing minimally invasive neuromodulation solutions, announced a significant milestone in its mission to transform chronic pain management. The company has successfully...

Hence then, the article about neuronoff announces safety and functionality success in first in human trial of injectrode for minimally invasive chronic pain relief life study was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study) )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News